STEVE ASELAGE - 24 May 2024 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
24 May 2024
Net transactions value
+$16,000
Form type
4
Filing time
29 May 2024, 16:16:35 UTC
Previous filing
20 Nov 2023
Next filing
14 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Purchase $16,000 +2,500 $6.40 2,500 24 May 2024 By Trust
holding BCRX Common Stock 63,339 24 May 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.